Literature DB >> 8119432

Visual disturbance of the uncovered eye in patients wearing an eye patch.

R B Ellingham1, A Waldock, R A Harrad.   

Abstract

We questioned 104 consecutive eye casualty patients about any visual disturbance experienced while wearing an eye patch as part of their treatment. Many (31%) reported momentary loss of vision in the uncovered eye. Some experienced this while driving. It was more common (p < 0.0008) if the 'dominant eye' had been patched (47%) rather than the 'non-dominant eye' (16%). In a separate experiment, a number of co-operative subjects were provided with a translucent-coloured occluder to be worn over each eye in turn. They reported a recurring coloured interference in the uncovered eye sparing the monocular crescent. We propose that the loss of vision in the unpatched eye is due to binocular rivalry suppression by the patched eye. This visual disturbance may be a cause of anxiety or risk for the patient. Patched patients should be warned this may occur, and advised to avoid driving or operating machinery.

Entities:  

Mesh:

Year:  1993        PMID: 8119432     DOI: 10.1038/eye.1993.182

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  Disease laterality, eye dominance, and visual handicap in patients with unilateral full thickness macular holes.

Authors:  K Waheed; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Mapping the binocular scotoma in macular degeneration.

Authors:  Cécile Vullings; Preeti Verghese
Journal:  J Vis       Date:  2021-03-01       Impact factor: 2.240

3.  Depth Perception and Grasp in Central Field Loss.

Authors:  Preeti Verghese; Terence L Tyson; Saeideh Ghahghaei; Donald C Fletcher
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

4.  VEP-based acuity estimation: unaffected by translucency of contralateral occlusion.

Authors:  Sven P Heinrich; Isabell Strübin; Michael Bach
Journal:  Doc Ophthalmol       Date:  2021-05-11       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.